Of 800 million boxes of medicine sold by the group, three-quarters are manufactured at our own pharmaceutical production sites, in France and abroad.

Note that 42% of Servier medicines are produced in and shipped from France. They are manufactured using active ingredients sourced exclusively in France, thus promoting employment and investment in the Centre and Normandy regions.

Our overseas production centers, in addition to Hungary, are located in Egypt, Spain, Ireland, Poland, China, Brazil, Mexico, Morocco, and Russia.

After a phase of considerable investment over the last decade in our Loiret (pharmacy) and Normandy (chemistry) sites, and in our overseas sites, notably in Russia, to meet our new drug development needs, industrial investment is now more modest and is in large part earmarked for maintenance of industrial equipment.